Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	OraSure Technologies	Cerus	Bioventus	Nyxoah	Orthofix Medical
Symbol	NASDAQ:OSUR	NASDAQ:CERS	NYSE:BVS	NASDAQ:NYXH	NASDAQ:OFIX
Price Information
Current Price	$11.18	$6.68	$14.91	$30.66	$39.32
50-Day Moving Average	$11.12	$5.91	$15.23	$31.30	$40.01
52-Week Low	$8.58	$4.67	$10.74	$23.15	$28.32
52-Week High	$17.79	$8.87	$19.94	$37.00	$48.50
MarketRank™
Overall Score	2.3	1.6	2.3	1.7	1.7
Analysis Score	3.3	0.0	3.4	3.5	1.0
Community Score	4.8	4.9	5.0	5.0	4.1
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	1.7	2.5	1.7	0.0	1.7
Earnings & Valuation Score	1.9	0.6	1.3	0.0	1.9
Analyst Ratings
Consensus Recommendation	Buy	N/A	Buy	Buy	Hold
Consensus Price Target	$15.83	N/A	$19.50	$42.00	$39.00
% Upside from Price Target	41.62% upside	N/A	30.78% upside	36.99% upside	-0.81% downside
Trade Information
Market Cap	$805.06 million	$1.15 billion	$847.62 million	$764.75 million	$774.41 million
Beta	-0.28	1.22	N/A	N/A	1.13
Average Volume	972,675	1,803,940	194,845	21,332	88,365
Sales & Book Value
Annual Revenue	$171.72 million	$91.92 million	$321.16 million	N/A	$406.56 million
Price / Sales	4.69	12.47	2.64	N/A	1.90
Cashflow	N/A	N/A	N/A	N/A	$1.96 per share
Price / Cash	N/A	N/A	N/A	N/A	20.04
Book Value	$5.56 per share	$0.62 per share	N/A	N/A	$18.37 per share
Price / Book	2.01	10.77	∞	N/A	2.14
Profitability
Net Income	$-14,920,000.00	$-59,860,000.00	$16.41 million	N/A	$2.52 million
EPS	($0.22)	($0.37)	$7.56	N/A	$0.26
Trailing P/E Ratio	159.71	N/A	1.97	0.00	N/A
Forward P/E Ratio	53.24	N/A	18.41	N/A	31.71
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	2.34%	-57.50%	N/A	N/A	-1.78%
Return on Equity (ROE)	1.33%	-62.92%	N/A	N/A	6.82%
Return on Assets (ROA)	1.17%	-27.93%	N/A	N/A	4.73%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	0.65%	0.76%	N/A	0.06%
Current Ratio	6.12%	2.82%	1.83%	N/A	3.17%
Quick Ratio	5.09%	2.34%	1.62%	N/A	2.17%
Ownership Information
Institutional Ownership Percentage	88.63%	88.16%	36.45%	0.77%	95.68%
Insider Ownership Percentage	1.70%	6.72%	N/A	N/A	4.00%
Miscellaneous
Employees	570	266	700	78	1,036
Shares Outstanding	72.01 million	171.63 million	56.85 million	24.94 million	19.70 million
Next Earnings Date	11/3/2021 (Estimated)	11/4/2021 (Estimated)	11/9/2021 (Estimated)	11/30/2021 (Estimated)	11/4/2021 (Estimated)
Optionable	Optionable	Optionable	Not Optionable	Not Optionable	Optionable

Source	Headline
	Orthofix Announces Appointment of Wayne Burris to Board of Directors finance.yahoo.com - September 23 at 9:34 AM
	Orthofix Announces Full Market Launch of Opus Mg Set – a Magnesium-based Settable Bone Void Filler for Orthopedic Procedures finance.yahoo.com - September 22 at 12:42 AM
	Devicemaker launches bone void filler for orthopedic surgeries beckersspine.com - September 21 at 7:41 PM
	Press Release: Orthofix Announces Participation in Upcoming Sidoti Virtual Investor Conference sharecast.com - September 20 at 7:25 AM
	Orthofix Announces Participation in Upcoming Sidoti Virtual Investor Conference finance.yahoo.com - September 20 at 7:25 AM
	Medical Bionic Implants Market is Expected to Grow Drastically, Assured By Experts From 2021 To 2027 globalbankingandfinance.com - September 18 at 5:45 PM
	$118.25 Million in Sales Expected for Orthofix Medical Inc. (NASDAQ:OFIX) This Quarter americanbankingnews.com - September 16 at 2:28 AM
	$0.17 Earnings Per Share Expected for Orthofix Medical Inc. (NASDAQ:OFIX) This Quarter americanbankingnews.com - September 14 at 5:16 PM
	Bone Growth Stimulation Devices Market 2021 \| Growth Drivers Challenges, Trends and Industry Dynamics, Forecast 2028 pharmiweb.com - September 10 at 2:30 AM
	Orthofix Medical's Return on Invested Capital Insights benzinga.com - September 9 at 4:10 PM
	Orthofix Medical (NASDAQ:OFIX) Releases FY 2021 Earnings Guidance americanbankingnews.com - September 3 at 7:24 AM
	Orthofix (OFIX) Fitbone Used in 1st US Pediatric Patient Implant finance.yahoo.com - September 2 at 5:21 PM
	Zimmer Biomet's smart knee implant, Aurora Spine's Q2 results & more: 7 device company notes beckersspine.com - September 1 at 5:17 PM
	Orthofix Announces First US Pediatric Implant of the Fitbone Limb-Lengthening System finance.yahoo.com - September 1 at 7:11 AM
	Orthofix Medical Inc. (NASDAQ:OFIX) Short Interest Up 22.6% in August americanbankingnews.com - August 31 at 3:50 PM
	Spinal Devices and Biologics Market Leading Players: Recent Industry Trends, Global Insights and Demand Growth, Size, Revenue 2021 to 2027 marketwatch.com - August 26 at 3:28 PM
	Orthofix Medical Inc.’S 3.81% Escalation Justifies Another Look stocksregister.com - August 21 at 4:35 PM
	Orthofix Medical Inc. barrons.com - August 12 at 10:36 PM
	Spine Surgery Medical Equipment Market 2021 Covid19 Impact Analysis Players are Medtronic (Ireland), DePuy Synthes (US) manometcurrent.com - August 9 at 2:20 PM
	How Much Did Orthofix Medical's(NASDAQ:OFIX) Shareholders Earn From Share Price Movements Over The Last Three Years? finance.yahoo.com - August 9 at 2:20 PM
	Orthofix Stock Ticks Up On Street-Beating Q2 Earnings; Raises FY21 Outlook markets.businessinsider.com - August 6 at 7:04 PM
	Orthofix ticks up on Street-beating Q2 results massdevice.com - August 6 at 2:04 PM
	Orthofix (OFIX) Tops Q2 Earnings and Revenue Estimates finance.yahoo.com - August 6 at 2:04 PM
	Orthofix: Q2 Earnings Snapshot sfgate.com - August 6 at 9:04 AM
	Orthofix Medical: Q2 Earnings Insights benzinga.com - August 6 at 9:04 AM

Date	Company	Brokerage	Action
9/22/2021	OraSure Technologies	Raymond James	Downgrade
9/20/2021	OraSure Technologies	Lake Street Capital	Boost Price Target
8/4/2021	OraSure Technologies	Raymond James	Boost Price Target
8/4/2021	OraSure Technologies	Lake Street Capital	Lower Price Target
8/4/2021	OraSure Technologies	Citigroup	Boost Price Target
7/28/2021	Nyxoah	Cantor Fitzgerald	Initiated Coverage
7/28/2021	Nyxoah	Piper Sandler	Initiated Coverage
7/27/2021	Nyxoah	Stifel Nicolaus	Initiated Coverage
7/6/2021	Nyxoah	Kepler Capital Markets	Reiterated Rating
7/1/2021	Bioventus	The Goldman Sachs Group	Downgrade
6/28/2021	OraSure Technologies	Raymond James	Lower Price Target
5/25/2021	Bioventus	Canaccord Genuity	Reiterated Rating
5/6/2021	OraSure Technologies	Lake Street Capital	Lower Price Target
5/6/2021	OraSure Technologies	Raymond James	Lower Price Target
4/19/2021	Bioventus	Morgan Stanley	Boost Price Target
3/8/2021	Bioventus	JPMorgan Chase & Co.	Initiated Coverage
3/8/2021	Bioventus	Morgan Stanley	Initiated Coverage
3/8/2021	Bioventus	The Goldman Sachs Group	Initiated Coverage
3/8/2021	Bioventus	Canaccord Genuity	Initiated Coverage
3/2/2021	OraSure Technologies	Citigroup	Lower Price Target
10/20/2020	Orthofix Medical	Stifel Nicolaus	Initiated Coverage
8/21/2020	OraSure Technologies	Evercore ISI	Initiated Coverage
8/10/2020	OraSure Technologies	Citigroup	Initiated Coverage
8/10/2020	OraSure Technologies	JPMorgan Chase & Co.	Initiated Coverage
8/7/2020	OraSure Technologies	Raymond James	Upgrade
6/25/2020	OraSure Technologies	Lake Street Capital	Initiated Coverage
6/15/2020	Cerus	Cantor Fitzgerald	Initiated Coverage
6/8/2020	Cerus	Cantor Fitzgerald	Reiterated Rating
5/27/2020	Cerus	Stifel Nicolaus	Boost Price Target
4/21/2020	OraSure Technologies	Stephens	Initiated Coverage
4/16/2020	Cerus	Stephens	Lower Price Target
2/26/2020	Cerus	BTIG Research	Initiated Coverage
2/25/2020	Orthofix Medical	Sidoti	Lower Price Target
2/25/2020	Orthofix Medical	Cantor Fitzgerald	Lower Price Target
11/13/2019	Cerus	BTIG Research	Upgrade
11/11/2019	OraSure Technologies	Canaccord Genuity	Reiterated Rating
10/29/2019	Orthofix Medical	Cantor Fitzgerald	Downgrade
8/27/2019	Cerus	Stifel Nicolaus	Initiated Coverage
8/22/2019	Cerus	Stephens	Initiated Coverage
8/14/2019	OraSure Technologies	Canaccord Genuity	Reiterated Rating
5/9/2019	OraSure Technologies	Canaccord Genuity	Downgrade
2/26/2019	Orthofix Medical	BTIG Research	Reiterated Rating
2/7/2019	OraSure Technologies	Canaccord Genuity	Reiterated Rating
1/18/2019	Orthofix Medical	Cantor Fitzgerald	Set Price Target
1/8/2019	Orthofix Medical	Cantor Fitzgerald	Set Price Target
12/18/2018	Cerus	Cantor Fitzgerald	Reiterated Rating
12/10/2018	Cerus	Cantor Fitzgerald	Reiterated Rating
10/23/2018	OraSure Technologies	Raymond James	Reiterated Rating
10/3/2018	Cerus	Cantor Fitzgerald	Reiterated Rating

(Data available from 9/23/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Resources

Premium Research Tools

Market Data and Calendars

Investing Education and Resources